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EXPOsOMICS  is  a European  Union  funded  project  that aims  to develop  a novel  approach  to  the  assessment
of  exposure  to high  priority  environmental  pollutants,  by characterizing  the  external  and  the  internal
components  of the  exposome.  It focuses  on air and  water  contaminants  during  critical  periods  of  life.
To  this  end,  the  project  centres  on  1)  exposure  assessment  at the  personal  and  population  levels  within
existing  European  short  and long-term  population  studies,  exploiting  available  tools  and  methods  which
have been  developed  for personal  exposure  monitoring  (PEM);  and  2) multiple  “omic”  technologies  for  the
analysis  of biological  samples  (internal  markers  of external  exposures).  The  search  for  the relationships
between  external  exposures  and global  proﬁles  of  molecular  features  in  the  same  individuals  constitutes
a  novel  advancement  towards  the  development  of  “next  generation  exposure  assessment”  for  environ-
mental  chemicals  and  their  mixtures.  The  linkage  with  disease  risks  opens  the  way  to  what  are  deﬁned
here  as  ‘exposome-wide  association  studies’  (EWAS).
©  2016  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CC
research, exposure data (including diet, lifestyle, environmental
and occupational factors) is often fragmentary (in time and depth),
non-standardized, at crude resolution and often does not include. Introduction and study design
It is generally accepted that the majority of important chronic
iseases are likely to result from the combination of environmental
xposures to chemical and physical stressors and human genet-Please cite this article in press as: Vineis, P., et al., The exposome in p
Health (2016), http://dx.doi.org/10.1016/j.ijheh.2016.08.001
cs. There is also evidence that the effects are location-speciﬁc and
nﬂuenced by climatic, lifestyle and socioeconomic characteristics.
lthough information on both environmental and genetic causes
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Box 1: A conceptual model of life-course disease risk.
Population studies of chronic diseases have traditionally
recruited middle-aged subjects. However, there is strong evi-
dence that (a) the risk of disease is influenced by early
exposures, including in utero; (b) life-stages include critical
(bearing long-term effects) and sensitive periods (susceptible
to large effects) (Ben-Shlomo and Kuh, 2002). The idea of a
sequence of critical and sensitive periods leads to the con-
cept of “chain of risk”, i.e. the interplay of early exposures
and late exposures. To use this concept in practice implies
having access to multiple life-stages in exposure assessment
and epidemiological studies, and repeated measurements of
biomarkers at different time windows. This approach requires
an inter-generational epidemiological study design and novel
statistical analyses.
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relatively prolonged time-periods, at the level of the individual sub-stimates at the level of the individual. The information on environ-
ental factors is often incomplete or inaccurate and the subsequent
stimation of overall risks associated with these factors is severely
indered. As a result, important associations can go undetected.
his limitation has recently been framed within the context of
he exposome, the environmental counterpart of the genome. The
oncept of the exposome refers to the totality of environmental
xposures from conception onwards, and has been described in
etail elsewhere including its external and internal components
Wild, 2005; Rappaport and Smith, 2010; Anon, 2016; Vineis et al.,
009).
The context of EXPOsOMICS is the rapidly developing ﬁeld
f exposure assessment, including the use of omic technologies,
ccording to the concept of the exposome. Historically, a key event
as the publication of the report Toxicity Testing in the 21 st Century:
 Vision and a Strategy by the US National Research Council in 2007.
he primary goals of the report were, among others: “(1) to provide
road coverage of chemicals, chemical mixtures, outcomes, and life
tages, (2) to reduce the cost and time of testing, (3) to develop
 more robust scientiﬁc basis for assessing health effects of envi-
onmental agents” (http://www.nap.edu/catalog/11970/toxicity-
esting-in-the-21st-century-a-vision-and-a). EXPOsOMICS aims at
artially covering points 1 (mixtures, outcomes, and life stages) and
.
By comprehensively addressing the integration of the external
nd the internal exposomes at the individual level, EXPOsOMICS
rovides a holistic and consolidated approach to exposure science.
uilding upon several EU-funded research projects with rich sets of
ealth data, exposure data, biomarker measurements and publicly
vailable data sources, this multidisciplinary project:
− Pools and integrates information from short-term,
xperimental human studies and long-term epidemiological
ohorts/consortia – including adults, children and newborns – to
nable focused investigations to reﬁne environmental exposure
ssessment based on the concept of life-course epidemiology (Box
 and Fig. 1).
− Characterizes the exposome, by (a) measuring the exter-
al component of the exposome at different critical life stages
y employing novel tools and drawing on experience gained in
xisting EU initiatives (PEM, databases coupled with GIS, remote
ensing), with a focus on air and water pollution; and (b) mea-
uring biomarkers of the internal exposome (xenobiotics and
etabolites), using omic technologies (adductome, metabolome,
ranscriptome, epigenome, proteome).
− Integrates external and internal exposure measures to com-Please cite this article in press as: Vineis, P., et al., The exposome in p
Health (2016), http://dx.doi.org/10.1016/j.ijheh.2016.08.001
rehensively model and assess exposure to air pollution and water
ontamination in large population cohorts, through novel statistical
odeling. PRESS
d Environmental Health xxx (2016) xxx–xxx
Together these approaches will lead to formulating a new con-
cept of integrated exposure assessment at the individual level,
reducing uncertainty, and assessing how these reﬁnements inﬂu-
ence disease risk estimates for combined, multiple exposures and
selected diseases.
The scientiﬁc questions to be addressed by the project are:
(1) Is it possible to reﬁne exposure assessment to air pollution and
water contaminants using a combination of personal exposure
monitoring and omic technologies?
(2) Will that reﬁnement lead to more accurate estimates of the
association with selected diseases, by reducing measurement
error?
(3) Do new approaches allow the investigation of the effects of
mixtures in addition to single components?
(4) Do they improve the investigation of dose-response relation-
ships?
(5) Is it possible to strengthen causal reasoning by using the
“meet-in-the-middle” concept, i.e. investigate the temporal
sequence of exposure, biological pathway perturbation and dis-
ease onset?
(6) Is it possible to use the exposome approach to study the life-
course epidemiology of environmental diseases?
2. External exposome (Fig. 2)
Existing population-based studies on environmental exposures,
such as the ESCAPE project (http://www.escapeproject.eu/), are
providing essential information on the disease risks associated with
exposure to air pollution, but they are limited in their exposure
assessment methodologies and because of the uncertain biolog-
ical plausibility of associations that are detected. Well-conceived,
fully controlled short-term intervention studies, such as the Oxford
Street Randomized Trial (included in the present project, ref.
(McCreanor and Cullinan et al., 2007 Dec 6)), and TAPAS have shown
that acute changes can occur in lung and heart function at low or
very low levels of exposure to air pollutants. Analogous studies have
been conducted on water contaminants, where genotoxic effects
have been observed (see below). The identiﬁcation of long-term
effects, however, has been problematic, due to the lack of the same
degree of accuracy in exposure assessment as obtained in short-
term experimental studies. The ﬁrst innovation of EXPOsOMICS is in
bringing together both types of investigations and in linking Personal
Exposure Monitoring (PEM) (high precision, used mostly in short-
term panel studies) with up-to-date land use regression modeling
and satellite-based exposure assessment. GPS-based techniques,
smartphones, accelerometers and PEM to detect pollutants can pro-
vide accurate and instant estimates of changes in human exposure
and in physical activity (de Nazelle et al., 2011; Dons et al., 2011;
Dippold, 2006). In addition, satellite modeling (e.g. aerosol optical
depth) is used for several purposes, including extension of expo-
sure models to areas not covered by other sources of information,
and retrospective assessment. EXPOsOMICS utilises and further
develops these technological advances in a combined manner for
the assessment of personal exposures, and to expand the assess-
ment to exposures that have not been geo-spatially addressed in
Europe to date (e.g. ultraﬁne particulates). By integrating technolo-
gies that provide estimates of exposure to multiple chemicals overractice: Design of the EXPOsOMICS project. Int. J. Hyg. Environ.
ject as well as populations, and at different life stages, our project
systematically explores and further develops the concept of the
exposome.
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Fig. 1. The conceptual framework of Exposomics (life-long integration of cohorts).
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Biomarkers of exposure that were developed during the past
ouple of decades (e.g. DNA and protein adducts), while repre-
enting a signiﬁcant step towards the deﬁnition of more accurate
easures of personal exposure, still suffer from the disadvan-
age of addressing single chemicals and covering therefore only a
mall fraction of the exposome. However, adaptation of biomarker
echnologies to provide a more global estimate of the internal
omponent of the exposome is emerging and is further devel-Please cite this article in press as: Vineis, P., et al., The exposome in p
Health (2016), http://dx.doi.org/10.1016/j.ijheh.2016.08.001
ped within EXPOsOMICS. For example, high-resolution LC/MS
Liquid Chromatography/Mass Spectrometry) metabolomics now
ermits the detection and characterisation of large numbers of
mall molecules, typically with molecular mass less than 2000 Da, monitoring to satellite integration.
in biological ﬂuids. This includes any metabolites that can be
affected by environmental exposures, and that can be related to
inﬂammation, oxidative stress and various metabolic pathways.
Analogous adductomic technologies will be pioneered to detect
protein adducts in an untargeted fashion, to provide a global pic-
ture of biomarkers of individual exposure either to electrophiles or
chemicals that are metabolically activated to electrophiles. Because
they can directly modify DNA and important proteins, reactive
electrophiles are important constituents of the exposome. Because
of their greater abundance and residence times in human blood,ractice: Design of the EXPOsOMICS project. Int. J. Hyg. Environ.
adducts on the circulating proteins hemoglobin and human serum
albumin (HSA) are preferable to those of DNA and glutathione for
characterizing adductomes (Rappaport et al., 2011).
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Box 2: Basic components of the EXPOsOMICS project.
Phase 1.
1. We have selected and integrated subjects, samples and data
from three types of existing studies: Experimental Short-Term
Studies (STS), Mother-Child Cohorts (MCO) and Adult Long-
Term Studies (ALTS), between them reflecting all life stages
from conception to old age.
2. We have measured the external exposome component for
air and water contaminants by performing extensive, repeated
Personal Exposure Monitoring (PEM). Fresh blood samples
have been collected from all the individuals undergoing PEM,
i.e. individuals in STS and those from a representative subsam-
ples from MCO and ALTS, selected on the basis of contrasting
exposures as estimated by traditional exposure assessment
methods. In these samples, plus already stored samples of the
recalled subjects from MCO and ALTS, EXPOsOMICS has con-
ducted untargeted omic analyses. The aim is to look for new
biomarkers of exposure to chemicals or mixtures and evaluate
intra-individual variation of the internal exposome.
Phase 2.
3. OMIC profiles were also measured in approximately 2000
stored samples from MCO and ALTS, using untargeted ana-
lytical methods, with the aim of evaluating them as predictive
of risk by examining their association with health effects, and
also generating new hypotheses on disease etiology.
4. We combine external and internal exposome data, Land Use
Regression models (LUR) and satellite data to calibrate air pol-
lution exposure estimates (e.g. PM2.5, ultra-fine particles, black
carbon) obtained using traditional methods in MCO/ALTS and
use these refined estimates for risk assessment and burden of
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mdisease evaluations.
In addition to global data on internal markers of expo-
ure, provided by these technologies, the internal component of
he exposome includes further biological proﬁle data generated
y high-density biological analysis technologies. Transcriptomic,
pigenomic and proteomic proﬁles of biological samples provide a
etailed picture of the evolving state of cells under the inﬂuence
f environmental chemicals, thus revealing early mechanistic links
ith potential health effects (Chadeau-Hyam et al., 2011; Lan et al.,
004; Smith et al., 2005).
. Population studies
The long-term cohorts used in EXPOsOMICS have been selected
n the basis of the following criteria: access to stored biological
amples, residential histories (for GIS based models), information
n confounders and ability to recall participants. Large studies have
een selected that cover wide geographic areas and have a wealth
f information including biomarkers, geo-referencing, follow-up
ata, and extensive behavioural and environmental variables. As it
s hypothesized that many internal exposome signatures are inﬂu-
nced by external exposures beyond air and water pollutants, study
opulations have been selected with available and accurate data on
ifestyle, anthropometry, nutritional and environmental factors.
The basic components of the project are described in Box 2.
Through the integration of a total of 14 studies of different
ypes, located in different regions, the project has generated a sub-
tantial amount of new data of continent-wide relevance. Phase 1
nvolves reﬁned exposure assessment based on the external (Per-
onal Exposure Monitoring) and the internal (omics) components
f the exposome, as well as (for comparison) exposure assessmentPlease cite this article in press as: Vineis, P., et al., The exposome in p
Health (2016), http://dx.doi.org/10.1016/j.ijheh.2016.08.001
sing traditional methods. This is performed in subjects partici-
ating in short-term experimental studies (STS) and in sub-sets of
epresentative subjects from population cohorts. The latter include
other-child cohorts (MCO) and adult long-term studies (ALTS). PRESS
d Environmental Health xxx (2016) xxx–xxx
Recalled subsets have been chosen at the extremes of exposure
(as estimated by traditional methods). For recalled subjects we
have conducted omic analyses on both freshly collected and stored
samples, thus providing repeated measurements of the internal
exposome. In Phase 2, omics are tested for their association with
health effects using additional untargeted analyses in samples from
ALTS and MCO, according to a case-cohort study design. In addi-
tion, the reﬁned exposure estimates derived from the external and
internal components of the exposome, which take into account
individual variation, are compared to estimates derived from tradi-
tional, less accurate exposure assessment methods, thus leading to
a calibration of estimates of exposure in long-term studies. Sub-
sequently the association of calibrated exposure estimates with
selected diseases is assessed.
Advantages of the chosen study design are that it makes it pos-
sible to:
(a) Link short-term experimental studies, having controlled expo-
sure conditions, with long-term studies in the same geographic
areas;
(b) Address the effects of common exposures at different life
stages;
(c) Address individual variability (in space and in time) through
repeated Personal Exposure Monitoring and omic measure-
ments in repeat blood samples;
(d) Incorporate individual variability and biomarkers of exposure
into exposure estimates and risk assessment for selected dis-
eases, thus reducing uncertainty in risk measures.
5. Experimental studies, short term effects (STS)
Short-term experimental studies on air pollution (Oxford Street
Randomized Trial, ref. (McCreanor and Cullinan et al., 2007); and
TAPAS) are utilized. In these studies volunteers are exposed to high
or low levels of air pollution within different urban contexts. During
each session, a number of outcome measurements (lung and heart
function) have been made while simultaneously measuring PM10-
2.5, PM2.5-0.1 and PM0.1. In addition to these measurements, in the
EXPOsOMICS project adductomics, metabolomics, transcriptomics,
and epigenomics are applied to evaluate the internal exposome on
blood samples collected before and after the exposure periods, to
search for biomarkers associating with acute exposures (PEM) and
acute health effects.
Exposure to water contaminants and their short-term effects
has been evaluated in the ongoing PISCINA experimental study
of swimmers in pools, where individuals have high exposure to
water disinfection by-products (DBPs) through skin absorption and
inhalation. Studies on swimmers have been found to be a good
model for high-exposure to DBPs in drinking water in the general
population. Existing PISCINA samples (ref. (Kogevinas et al., 2010;
Richardson et al., 2010)) have been complemented, in this project,
with additional samples collected from swimmers in pools with
different levels of water DBPs. The external and internal exposome
have been measured in these individuals before and after swim-
ming and complemented, for purposes of phenotypic anchoring
(i.e. of correlating with phenotypic effects) (Kogevinas et al., 2010),
with measurements of micronuclei in blood and urine, bacterial
mutagenicity (of urine samples), and inﬂammation and oxidative
stress markers.
6. Observational life-course studies: mother-child cohortsractice: Design of the EXPOsOMICS project. Int. J. Hyg. Environ.
(MCO) and adult long-term studies (ALTS)
In Phase 1, measurements of the internal and external expo-
some have been made in representative subjects of (a) ﬁve birth
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ohorts (RHEA, ENVIRONAGE, INMA, ALSPAC and PICCOLI+), (b) the
PIC, ECRHS and SAPALDIA adult cohorts, exploiting data gener-
ted within the large ESCAPE consortium for air pollution, and (c)
 study on colon cancer (MCC-Spain) used for the investigation of
ater pollution.
These data are utilized for in-depth studies aimed at the devel-
pment of improved exposure estimates based on the external and
nternal exposome concept in a chronic exposure context. Some of
he above cohorts have stored samples of venous blood collected
t different times of follow-up and most of the birth cohorts have
ord blood. We  reconstruct the in utero exposome based on cord
lood samples integrating different potential critical exposure win-
ows of air pollution exposure. Epidemiological and public health
igniﬁcance of the in utero exposome will be investigated based
n associations with child health and development including birth
eight, growth, obesity and other outcomes.
. Exposures
.1. Air pollution
Epidemiological studies have traditionally assigned exposure
ased on monitoring results of a central monitoring site in the city
f residence (Jerrett et al., 2005). In the last decade, methods for
ore individual exposure estimates have been applied, including
and use regression models (LUR) and dispersion models (Jerrett
t al., 2005; Hoek et al., 2008). A number of studies have shown
ifferences between long-term average personal and ambient air
ollution exposure (Van Roosbroeck et al., 2005). In the latter stud-
es, integrated personal samplers were used that provided a single
ample over 1–2 days. Hence no assessment of the contribution of
ifferent microenvironments to total exposure (and difference) was
ossible.
Recent advances in air pollution monitoring technology mean
hat personal monitoring can be undertaken with real-time moni-
ors, capable of logging minute-to-minute variability in exposures.
ensors are portable and sensitive. Coupling the new air pollu-
ion monitors with GPS and accelerometry from smartphones,
nd information on personal activity patterns, the potential now
xists to differentiate between exposure during journeys and
xed-site locations and to assess the contribution of different
icro-environments to the magnitude and variability of environ-
ental exposures. However, no product existed at the outset of
XPOsOMICS that integrated these technologies into a single per-
onal monitoring system that can be deployed with lay users (e.g.
ohorts), a problem that has been addressed by the current project
see below).
To date, the majority of evidence about the health effects of
ir pollution from epidemiology and controlled exposure studies is
ased on particle mass as the measure of exposure. Consequently,
egulatory agencies have adopted mass-based ambient air quality
tandards. Yet particulate matter (PM) is a complex mixture, and
articles of different size and composition are likely to have differ-
nt toxic effects. The EU-funded ESCAPE study has comprehensively
haracterized sources of outdoor air pollution and developed ambi-
nt LUR models for PM10, PM2.5 and NO2. Models are currently in
evelopment for elemental composition (XRF; X-ray ﬂuorescence),
C/OC (elemental carbon/organic carbon) and PAHs (polycyclic aro-
atic hydrocarbons). There is, however, a need to develop models
or ultraﬁne particles for which the long-term health effects havePlease cite this article in press as: Vineis, P., et al., The exposome in p
Health (2016), http://dx.doi.org/10.1016/j.ijheh.2016.08.001
een poorly studied because of difﬁculties in exposure assessment.
his is now possible using an innovative mobile monitoring design
hat has been shown to be reliable and cost-effective in recent
tudies (Klompmaker et al., 2015; Montagne et al., 2015). PRESS
d Environmental Health xxx (2016) xxx–xxx 5
One of the properties of particles likely to reﬂect toxicity is
their oxidative potential (OP). By analyzing the spatial and tem-
poral variability of the OP of particulate matter collected on ﬁlters,
the determinants of that variation are characterized, and new, spa-
tially resolved air pollution models for OP have been developed.
The air pollution models alone, however, only provide information
on ambient outdoor pollutant concentrations. Recent advances in
GIS (e.g. route modeling) (Gulliver and Briggs, 2005) and micro-
environmental models (e.g. indoor-to-outdoor), have led to the
development of more detailed, personal exposure models which
can be fed by rich data sources on detailed population time-activity
patterns.
To advance the state of the art EXPOsOMICS provides an inno-
vative framework for air pollution external exposome, via the
following steps:
1) The scientiﬁc partners have integrated instruments from equip-
ment manufacturers (e.g. DiSCmini for UFP and BGI pump for
PM2.5) to develop a novel integrated personal monitoring sys-
tem comprising UFP and PM2.5 personal air monitors with
smartphone technology aimed at characterization of micro-
environments, activity patterns, and inhalation rates. One  of the
main technological innovations is the collection of various mea-
surements and the ability to access them via a single source (i.e.
smartphone).
2) Deploy the new personal monitoring system among cohort
members in a subset of ﬁve study areas, covering different sites
(e.g. city centre, suburban, industrial, and rural), to collect the
largest series of detailed personal exposure measurements of
UFP, PM2.5 and activity data in Europe to date (with simultane-
ously collected blood samples for omics).
3) Develop models in longitudinal studies such as ESCAPE (http://
www.escapeproject.eu/), enriched for all the cohorts in the
study, and develop methods to transfer these models of air pol-
lution concentrations back in time.
4) Undertake an UFP air pollution “mobile monitoring campaign”
in the study areas where we also perform PEM to develop and
validate the new land-use regression models for UFP.
5) Apply the OP depletion analysis technique to extend PM metrics
to look at OP. PM2.5 ﬁlters collected during ﬁxed-site outdoor
monitoring in selected ESCAPE areas have been analysed to
detect the spatial and temporal variability in PM2.5-related OP
and subsequently create new land-use regression models for
OP. We  compare and assess the spatio-temporal differences in
exposure estimates between OP with those from traditional par-
ticulate metrics (e.g. PM10, PM2.5).
6) Compare PEMs in 3) above with those from residential address
locations to quantify the correlation between the two. We  fur-
ther quantify the spatial and temporal micro-environmental
contributions to total exposures.
7) Assess the potential for exposure variability (or misclassiﬁca-
tion) in exposures, e.g. for UFP and PM2.5 where we have both
LUR models and measured exposures. Compare traditional (i.e.
residential address) and new methods to inform the omic studies
(see below) and health risk assessment.
8) Develop a new Europe-wide air pollution model for PM2.5 and
methods to apply exposure models for the other pollutants (OP,
UFP) to other cohorts and across Europe for health risk assess-
ment. In order to develop exposure models for the pollutants
being studied in the external exposome, which can be appliedractice: Design of the EXPOsOMICS project. Int. J. Hyg. Environ.
to health risk assessment, the transferability of the new LUR
models and hybrid models to other countries/regions and time
periods is investigated. Develop models which incorporate satel-
lite data either as variables to enhance existing approaches or as
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a means of calibrating/validating models in areas where routine
monitoring data are sparse or do not exist.
) Provide model estimates for single and multiple exposures
(i.e. mixtures) to feed into risk models (e.g. partial least-
square regression, ridge regression, Bayesian mixture methods)
(Chadeau-Hyam et al., 2013a; Agier et al., 2016a) to study the
contribution of single compounds and combination of com-
pounds to adverse health effects in children and adults.
.2. Water contamination
EXPOsOMICS makes use of existing short-term experimental
tudies (STS) and of long-term population studies (MCO and ALTS).
or the short-term scale (PISCINA study) direct measurements of
peciﬁc chemicals and mixtures in water have mainly been used,
hile for the life-course studies a combination of models with
easurements for validation purposes, smart phone technology,
xtensive use of databases, remote sensing and land use maps
re used. European-based estimates have been obtained further
hrough systematic use of regional and national databases for dis-
nfection by-products (DBPs).
.2.1. Personal and micro-environmental exposure
easurements (Fig. 2)
In the PISCINA swimming pool study, external exposure
easurements include determination of an expanded range
f disinfection by-products (DBP) (trihalomethanes, haloacetic
cids, MX,  chloramines, haloacetonitriles), overcoming traditional
pproaches that measure only trihalomethanes. These chemi-
als have been measured in air and water and/or in biological
amples such as exhaled breath (e.g. trihalomethanes) and urine
haloacetic acids) from study subjects. The external exposome
s complemented with omic analyses and supported (for pheno-
ypic anchoring) by in vitro assays such as the Salmonella (Ames)
utagenicity test (Maron and Ames, 1983) and mammalian cell
hronic and acute cytotoxicity and the SCGE (comet) assay (van
eeuwen et al., 2006). Biological samples (blood, urine, exhaled
reath condensate) have been obtained immediately before and
fter swimming in the pool. Repeated biological samples have been
ollected after swimming to cover different formation/elimination
inetics of biomarkers, thus contributing to an improved quantita-
ive evaluation of internal exposures.
.2.2. Long-term exposure assessment
In the mother-child cohorts, external exposure measure-
ent includes determinations of a range of DBP chemicals in
rinking water (trihalomethanes, haloacetic acids, MX,  haloace-
onitriles). Measurements for some of these chemicals are
vailable from the EU-funded HiWate project (https://www.
esearchgate.net/publication/24037941 Health Impacts of Long-
erm Exposure to Disinfection By-Products in Drinking Water
n Europe Hiwate). In the colorectal cancer study (MCC), exposure
odeling of DBPs is based on the evaluation of lifetime residential
istory together with the collection of historical information on
BPs in the relevant regions and water toxicity testing from the
hort-term studies.
.2.3. European-wide water-borne exposure models for health
isk assessment
Exposure to speciﬁc DBPs is derived for European populationsPlease cite this article in press as: Vineis, P., et al., The exposome in p
Health (2016), http://dx.doi.org/10.1016/j.ijheh.2016.08.001
rom routinely collected information in each country. These data,
ot centrally available in the EU, come from focus contact points
n each country (expanding work completed in INTARESE, and
iWate). In addition a theoretical framework for future routine PRESS
d Environmental Health xxx (2016) xxx–xxx
evaluation of water contaminant information in Europe is pro-
posed.
7.3. Internal exposome: omics
By permitting the simultaneous analysis of large numbers of
potential targets without recourse to prior hypotheses, omic tech-
nologies provide unique opportunities for the discovery of a new
generation of biomarkers of exposure and disease risk, signiﬁ-
cantly enriched by mechanistic information (Chadeau-Hyam et al.,
2011; Lan et al., 2004; Smith et al., 2005; Perera et al., 2009;
Zhang et al., 2016a; Zhang et al., 2016b; Bictash et al., 2010;
Nicholson and Rantalainen et al., 2011; Wang-Sattler and Yu et al.,
2008; Holmes et al., 2008; Calderón-Garciduen˜as et al., 2004).
The EXPOsOMICS project both advances omic technologies that
are related to identiﬁcation and quantiﬁcation of environmen-
tal exposure (metabolomics, adductomics) and applies multiplex
omic technologies that measure downstream effects of environ-
mental exposures (epigenome, transcripts, miRNA, proteins). Omic
technologies are deployed in an untargeted manner in both the
short-term and the long-term studies, to a total of approximately
3000 samples (Table 1). The subjects for untargeted omics in
Phase 1 were selected on the basis of extreme exposures. Publicly
available toxicogenomics databases have been explored to iden-
tify candidate omic-based exposure biomarkers. Databases are the
diXA data infrastructure (FP7 project: diXA) and the US Compara-
tive Toxicogenomics Data Base (http://ctdbase.org/). These contain
both in vitro and in vivo toxicogenomic data and, to a degree, omic
results from exposed humans, and have links to important chemical
toxicity databases such as the US NTP and the OECD eChemPortal.
We will attempt to replicate the signals of Phase 1 in selected case-
cohort studies for a total of approximately 2000 subjects. One of
the main products of the consortium will be endophenotypes, i.e.
intermediate phenotypes common to several diseases.
Untargeted omic analyses in general are conducted in subjects
for whom the external exposome has been measured and, where
possible, all omic platforms are used in the same subjects to enable
cross-omic analyses.
7.3.1. Metabolomics (MS technology) (Fig. 3)
Plasma or serum samples have been analysed by high resolu-
tion mass spectrometry (MS) coupled to UPLC. Metabolic features
characterizing exposed groups are identiﬁed by multivariate statis-
tics with appropriate correction for the False Discovery Rate (FDR),
and efforts to identify the discriminating metabolites are made. A
database of known biomarkers from the main environmental con-
taminants in air and water as measured in various populations has
been compiled from the scientiﬁc literature into the Exposome-
Explorer database (http://exposome-explorer.iarc.fr/).
7.3.2. Adductomics
Application of adductomics to the exposome concept involves
an untargeted investigation of the internal exposome based on
the measurement of complete categories of features (e.g. protein
adducts). The untargeted approach has been realised by focusing
on a speciﬁc locus of HSA, and using MS  of hydrolysis products to
proﬁle covalent modiﬁcations over a range of masses.
7.3.3. Intermediate omic biomarkers
Additional omic technologies for the analysis of biologicalractice: Design of the EXPOsOMICS project. Int. J. Hyg. Environ.
molecules have been used to measure the more downstream effects
of environmental exposures. These include the effect on the tran-
scriptome, the epigenome and the proteome. Measurements have
been conducted using:
Please cite this article in press as: Vineis, P., et al., The exposome in practice: Design of the EXPOsOMICS project. Int. J. Hyg. Environ.
Health (2016), http://dx.doi.org/10.1016/j.ijheh.2016.08.001
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Table  1
Characteristics of the cohorts.
Type of study Cohort Study Characteristics
Experimental Studies Oxford Street The study is a randomized cross-over trial on the acute effects of ambient exposure to trafﬁc and
exacerbations of cardiovascular and chronic pulmonary disease. 59 adults were recruited for the EXPOsOMICs
project: 20 healthy adults, 20 COPD (Chronic Obstructive Pulmonary Disease) and 19 IHD (Ischaemic Heart
Disease). They were invited to walk in Oxford Street (high exposure) or in Hyde Park (low exposure), London.
A  series of clinical, physiological and inﬂammatory responses are compared between the two exposures and
to  those measured in healthy controls undergoing similar exposures, as well as various omics measurements
(transcriptomics, metabolomics, adductomics) obtained before, 4 h after and 24 h after walking.
TAPAS Barcelona The TAPAS 2 Barcelona study follows a crossover study design involving 30 healthy, non-smoking adults in
the  age range of 18–60. Volunteers were exposed from 8am to 10am to either heavily polluted air (busy street
in  morning rush hour, trafﬁc site) or to low dense trafﬁc air pollution (control site) in Barcelona, Spain. Six
subjects were studied simultaneously on each study day: three of them performed moderate physical activity,
riding an ergometer (intermittent 15 min  cycling and 15 min  break) while the other three volunteers stayed at
rest. Participants that performed physical activity had to cycle at such a pace that their heart rate was 50–70%
of  their maximum rate.
PISCINA2 The experimental PISCINA2 study – consisting of 60 healthy non-smoking volunteers – assessed a) exposure
to  chlorination by products in swimmers, b) short-term respiratory health effects and c) genetic damage after
swimming. Blood, urine, and exhaled breath condensate (EBC) were collected from the volunteers before and
immediately after swimming in a chlorinated pool for 40 min. Transcriptomics, metabolomics, adductomics
and concentrations of selected inﬂammatory markers were measured in blood samples obtained before and
2  h after the experiment.
Mother-Child Cohorts RHEA
Mother-Child
Study in Crete
The mother-child “Rhea” study in Crete is a prospective cohort examining a population sample of pregnant
women and their children, at the prefecture of Heraklion (n = 1500). The study aims are to evaluate a)
nutritional, environmental, biological and psychosocial exposures in the prenatal period and in early
childhood, b) the association of these exposures with the development of the foetus and the child, c) mother’s
health during and after pregnancy, and d) genetic susceptibility and the interactions between genetic and
environmental factors affecting child health. A set of 100 children from the RHEA-cohort is included in the
EXPOsOMICS children studies, for which data on cord blood DNA-methylation, metabolomics, proteomics and
albumin adducts are available.
INMA
Environment and
Childhood
The INMA − INfancia y Medio Ambiente (Environment and Childhood) project follows up a population
sample of around 3100 pregnant mothers and newborns. New and existing cohorts of pregnant women have
been incorporated from seven different Spanish regions. Pregnant women are assessed at 12, 20 and 32 weeks
of  gestation to collect information about environmental exposures and foetal growth. Children are assessed at
birth, at the age of 1 year and at the age of 4 years. The cohorts have been designed to evaluate the impact of
environmental exposures and diet on children’s health. A set of 100 children from the INMA centre Sabadell is
included in the EXPOsOMICS children studies, for which data on cord blood metabolomics, proteomics and
albumin adducts are available.
ALSPAC
The Avon
Longitudinal Study
of  Parents and
Children
ALSPAC recruited more than 14,000 pregnant women with estimated dates of delivery between April 1991
and  December 1992. Outcomes include prenatal and birth health events, growth, neurodevelopment,
behavioural functioning, lung function and cardiovascular measurements. Nitrogen oxide levels and PM10
estimates based on home location are available for the in utero and early life period. A set of 2300 children
from  the ALSPAC study is included in the EXPOsOMICS children studies, for which data on metabolomics at 7
years  of age is available. DNA methylation for 650 children is available in cord blood and at 7 and 15 years of
age. Also information about growth trajectories, asthma/lung function and neurocognitive tests are available.
Piccoli+ Piccoli+ is a multicentric Italian birth cohort that recruited 3000 new-borns and their mothers in 5 centres:
Turin, Trieste, Florence, Viareggio and Rome (www.piccolipiu.it). Participants receive a follow-up interview 6,
12  and 24 months after delivery and a medical examination when the children turn 4. Growth trajectories and
neurocognitive test-results are available. A set of 99 children from the Turin centre is included in the
EXPOsOMICS children studies, for which data on cord blood DNA methylation, metabolomics, proteomics and
albumin adducts are available.
EnvironAge
ENVIROnmental
inﬂuence ON
AGEing in early life
The ENVIRonAGE (ENVIRonmental inﬂuence ON AGEing in early life) cohort includes 1300 mother-infant
pairs  and further recruitment is ongoing. Data include mothers’ lifestyle and socio-economic status,
gestational history, measurements including the new-borns’ blood pressure (all healthy with gestational age
37–42  weeks), bio banked placental tissue and cord blood including RNA/DNA, toxic metals in cord blood and
placenta, and in utero and early life exposure to ﬁne particulates and NO2 using a spatial temporal
interpolation method. A set of 200 children from the ENVIRonAGE-cohort is included in the EXPOsOMICS
children studies, for which data on cord blood DNA methylation, transcriptomics, metabolomics, proteomics
and  albumin adducts are available.
Adult Cohorts and
Case-Control Studies
SAPALDIA The SAPALDIA Cohort was recruited at baseline in 1991 as random samples from population registries of 8
different communities. The aim is to investigate the various determinants − including environmental and
genetic − of asthma in adults. Exposure modeling included area speciﬁc outdoor models of the key pollutants
(UFP, PM2.5, PM10, NO2 and PM2.5 chemical constituents including soot, trace metals and inorganic ions).
Blood and DNA samples were collected into a biobank at the ﬁrst and second follow-up and the cohort has
genome-wide data on over 4000 participants. Sapaldia provides 200 asthma cases and their matched controls
to  EXPOsOMICS. Matching is by smoking (never/time since quitting), gender, age groups, season of
recruitment, year of recruitment in the cohort.
European
Community
Respiratory Health
Survey
(Norwich and
Barcelona)
The European Community Respiratory Health Survey (ECRHS) included sites in East Anglia and in
Barcelona. In 1991/2 random samples of adults aged 20–44 were invited to complete a short questionnaire
asking about symptoms of asthma (n = 3000 in each centre). Random subsamples (plus additional cases with
symptoms suggestive of asthma) underwent extensive clinical investigation including extended
questionnaires on allergic and lung symptoms, use of health services and indoor/occupational exposures.
Spirometry (baseline and 2 follow-ups), and information on atopy (baseline and two  follow-ups),
self-reported respiratory symptoms, and allergic diseases were collected. Participants in Norwich, East Anglia
participated in PEM (see below). 40 asthma cases and 40 matched control participated in EXPOsOMICS from
Barcelona, Spain. Matching by smoking (never/time since quitting), gender, age groups, season of recruitment,
year  of recruitment in the cohort.
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Table 1 (Continued)
Type of study Cohort Study Characteristics
EPIC CVD EPIC is a multicenter prospective cohort study,  which recruited 518,408 volunteers from 23 centres in 10
countries (Sweden, Denmark, Norway, the Netherlands, United Kingdom, France, Germany, Spain, Italy, and
Greece) between 1992 and 2000. The study population included volunteers aged mostly 25–70 years at the
time  of recruitment. Cancer incidence, mortality data and incident CVD events were obtained at the regional
level. Cases of cardiovascular disease and controls were identiﬁed within existing cohorts of EPIC Italy (Torino
n  = 180 and Varese n = 208) and with archived blood samples available. In Italy, incident cases were identiﬁed
via  clinical records and validated by a cardiologist. Other criteria for selection: only never smokers and
ex-smokers since at least 1 year, and an equal number of men and women. Matching by smoking (never/time
since quitting), gender, age groups, season of recruitment, year of recruitment in the cohort.
Multi Cancer
Control Study
Spain (MCC)
MCC-Spain is a multi-case-control study conducted in 11 Spanish provinces with the aim to evaluate
environmental and genetic factors associated with prevalent tumours, using a common set of population
based controls. Incident cases and population-based matched controls 20–85 years old have been recruited in
Barcelona, Madrid, León, Murcia, Gipuzkoa, Navarra, Asturias, Granada, Huelva, Valencia and Cantabria
provinces between 2007 and 2013. The cancer sites evaluated are colorectal, breast, prostate, gastric and
lymphocytic chronic leukaemia. The study population participating in the EXPOsOMICS project includes 200
cases  of colorectal cancer and 200 controls.
Personal Exposure
Monitoring (PEM)
PEM have been performed in subsamples of existing cohorts in ﬁve study Areas (Italy (IT n = 42), the
Netherlands (NL = 44), Spain (SP = 40), Switzerland (CH = 48), and the United Kingdom (UK = 31)). In IT, NL, CH
and  UK adults were recruited; in SP children aged 8–12 years old. All subjects carried a backpack containing
air  pollution sensors and batteries, and a belt containing a smartphone (and also separate GPS and
accelerometer in some areas) for 24 h to measure individual exposure to PM2.5 and UFP. The study took place
over a year period during three different seasons (Summer, Winter and Spring/Autumn). After each PEM
session, a blood sample was collected for OMICs Analysis in all adults. To interpret the air pollution and
biological measurements, a set of questionnaires was administered to the participants.
F  hits) 
U d (cou
•
•
©
©ig. 3. Internal Exposome – PISCINA study – Metabolomic analysis (PLS-DA and top
ntargeted metabolomics of blood samples. N = 3761 metabolomic features detecte
Transcriptomics (Agilent platform) (number of signals per sam-
ple: 44 k)
Epigenomics:Please cite this article in press as: Vineis, P., et al., The exposome in p
Health (2016), http://dx.doi.org/10.1016/j.ijheh.2016.08.001
 Global DNA methylation (Illumina platform) (number of signals
per sample: 450 k)
 microRNA analysis (Agilent platform) (number of signals per
sample > 1000)– Exposure to disinfection by-products and their short-term effects in swimmers –
rtesy K Van Veldhoven).
• Targeted proteomics (Luminex Multianalyte Proﬁling platform
for inﬂammation-related proteins) (number of signals per sample
∼30).
8. Data analysesractice: Design of the EXPOsOMICS project. Int. J. Hyg. Environ.
8.1. Data processing and integration: data analysis
This project has created a dedicated data infrastructure by
building on existing data repositories to avoid redundancy (at the
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enedata SME). We  have deﬁned query methods, workﬂows for
uality control, data harmonization and normalization in order to
ake all the data available for integrated analysis. Data integra-
ion includes ﬁve types of data: (a) data from existing databases
e.g. OMI, diXA, CTDB); (b) external exposure data from experimen-
al/observational population studies; (c) untargeted omic data; (d)
ealth information from cohorts, in different age groups; and (e)
ther exposures from cohorts (confounders, effect modiﬁers).
The complexity of the project design and data collected poses
ew methodological and analytical data challenges. Main such
hallenges are: developing data analytics to address multiple
xposures (both external and internal) in exposome-phenome
ssociation studies; identiﬁcation of statistical tools to address
he hierarchical structure within external and internal exposure
ata (e.g. cross-omics analyses); and implementing analytical tools
o address the dynamics of the exposome-phenome associations
ver life. A ﬁrst effort has been made by comparing the perfor-
ances of linear regression based statistical methods in assessing
xposome-phenome associations. In an extensive simulation study
sing realistic empirical exposome data we have shown that corre-
ation between exposures is indeed a major challenge for exposome
esearch, and that current statistical methods are limited in their
bility to efﬁciently differentiate true predictors from correlated
ovariates. However, some currently available methods like GUESS
nd DSA do provide a marginally better balance between sensitivity
nd FDP, although they did not outperform the other multivariate
ethods across all scenarios and properties examined. Future work
n Exposomics is focused on extending these methods to be able
o adopt the aforementioned computational complexity and to be
ble to incorporate external information from previous research,
etwork ontologies, and biological pathways. Some details can be
ound in methodological papers that have emerged from the col-
aboration between EXPOsOMICS and HELIX (Agier et al., 2016b;
hadeau-Hyam et al., 2013b).
.2. Exposure calibration
The multidisciplinary expertise of the EXPOsOMICS group
nables the collection, in several populations, of modeled expo-
ures based on reﬁned models and cutting edge technologies, as
ell as PEM. Based on samples in which both types of data are avail-
ble, we deﬁne calibration coefﬁcients to optimize the prediction of
rue exposure (from PEM studies) from combinations of variables in
he modeled exposure matrices. Statistical methods include clas-
ical measurement error models and their Bayesian alternatives
roviding calibrated exposure estimates for air and water pollu-
ants. The resulting estimates are used within EXPOsOMICS a) for
he characterization of the internal response to the external com-
onent of the exposome and b) to study the association between
he calibrated exposures and disease endpoints.
.3. Development, validation and investigation of internal
arkers of external exposures
EXPOsOMICS has provided a large range of −omic proﬁles in
opulations where PEM and calibrated exposures are also available.
uch analyses rely on the adaptation, in the exposome concept, of
ethods employed in GWAS. Mainly we use as a benchmark uni-
ariate approaches (linear or generalized linear models) coupled
o ad-hoc multiple testing correction and FDR control techniques.
ayesian variable selection methods, typically seeking the best
ombination of markers (omic signals) to predict the outcomePlease cite this article in press as: Vineis, P., et al., The exposome in p
Health (2016), http://dx.doi.org/10.1016/j.ijheh.2016.08.001
exposure levels) are used here for the ﬁrst time. In addition, these
nalyses provide an estimate of the variance in individual responses
t similar exposure levels. Finally, in order to identify potential
ommon patterns in the internal signature of exposures across PRESS
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platforms, the correlations between proﬁles from each platform are
analysed with respect to the external exposures. These ‘cross-omic’
analyses potentially identify features of the biological pathways
linking exposure to disease risk, and rely on well-established meth-
ods such as network and clustering methods.
8.4. Risk analyses
The calibration algorithms and estimates of measurement error
and inter-individual differences in biological responses are used to
perform updated risk analyses in the short- and long-term effect
studies, using standard parametric and non-parametric risk func-
tions and advanced risk analysis procedures that account for the
contributing effects of often-correlated exposures (e.g. partial least
square regression, ridge regression, and Bayesian mixture models).
In the short-term studies (such as the Oxford Street Randomized
Trial) EXPOsOMICS relates the external and internal exposome
markers and proﬁles to acute outcomes such as pulmonary function
measures, other patho-physiological outcomes, heart function and
asthma episodes. For PISCINA, correlations between external and
internal exposome markers are investigated together with geno-
toxicity outcomes. In the long-term studies the calibrated exposure
estimates and internal exposure markers are applied to study the
association between subfractions of air pollution (PMs, UFP, and
oxidative stress potential), water contaminants and health out-
comes in different areas of Europe. This project uses case-cohort
studies within the pooled cohorts, in two  ways. In Phase 2 risk esti-
mates for selected diseases are performed, i.e. asthma (in adults
and children), CVD and colon cancer in adults, and neurodevelop-
ment in children, for a total of approximately 1100 cases and 1100
controls. For these subjects the consortium has complete data on
targeted analyses, PEM-calibrated exposure assessment, and well-
phenotyped disease outcomes. We have performed untargeted
omic analyses in Phase 2, to allow us to generate new hypothe-
ses on the etiology of the selected health outcomes, but also to
test whether the omic candidates selected from Phase 1 (asso-
ciated with exposures) predict the risk of disease. Subsequently,
these analyses are extended to risk analyses of groups of 500–1000
cases for major diseases that have been associated with air pol-
lution or water contamination, and the corresponding controls. In
this enlarged risk estimation exercise, exposure calibration based
on Phases 1 and 2 is extended to exposure assessment for a total
of several thousands of subjects in Europe. Lastly, the inclusion of
adult and children cohorts using the same external and internal
exposome methodologies allows the investigation of age-speciﬁc
responses to environmental exposures at critical life stages.
9. Conclusions and lessons learned
EXPOsOMICS is one of the ﬁrst sizable projects on the expo-
some. Though the original concept of the exposome implies that
the study of all life-course exposures needs to be considered, this
goal is currently clearly not achievable by a single investigation. We
chose therefore to focus on air pollution and water contaminants
as two  common sets of exposures, and to explore the life-course
by linking population studies recruited at different ages. There are
several challenges in the study we  are undertaking, which include
the uncertainty in ﬁnding meaningful omic signals from low or
very low environmental exposures; the ability to investigate mix-
tures (i.e. leading to effects that are different from the sum of single
exposures); the ability to investigate dose-response relationshipsractice: Design of the EXPOsOMICS project. Int. J. Hyg. Environ.
with sufﬁcient power; the challenge of extrapolating Phase 2 ﬁnd-
ings (in nested case-control studies) to Phase 3, i.e. in larger cohort
studies, after correction for measurement errors. There are also lim-
itations in our project, namely the limited sample size and the lack
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f repeated samples in cohorts; this is an incentive to establish con-
ections with similar projects and plan pooled or meta-analyses.
he main lessons learned are: (a) it is difﬁcult to harmonize sev-
ral small studies in the attempt of linking age groups, and a single
arge cohort encompassing all ages, with long follow-up and with
epeated samples would be better suited. In the current project
e are taking a statistical approach that links together the differ-
nt studies, treating them as phases of a life-long experience, but
his approach has its own limitations (particularly power and com-
arability). (b) Exposure measurement technologies are rapidly
volving and such evolution needs to be monitored in the years
head to allow a rapid incorporation into epidemiological studies.
n spite of cost reduction it is likely that for a long time incorporation
f the new sensors will be possible only in hundreds or thousands
f subjects, thus making the approach we have used (calibration)
 realistic and concrete way ahead. (c) The same applies to omic
echnologies, with the additional need to evaluate their reliability
nd applicability to samples stored from large cohorts.
The data produced by EXPOsOMICS will be made publicly avail-
ble.
More than a decade after the original publication of the expo-
ome concept, followed by years of discussions on deﬁnitions and
hallenges of implementing the concept into research, the time
as now come to move the concept from theory to practice. EXPO-
OMICS serves as a proof-of-principle of the exposome concept and
hrough its implementation it will inform future exposome studies.
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